Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

Kim M. Linton*, Umberto Vitolo, Wojciech Jurczak, Pieternella J. Lugtenburg, Emmanuel Gyan, Anna Sureda, Jacob Haaber Christensen, Brian Hess, Hervé Tilly, Raul Cordoba, David John Lewis, Craig Okada, Martin Hutchings, Michael Roost Clausen, Juan Manuel Sancho, Tara Cochrane, Sirpa Leppä, Martine E.D. Chamuleau, Diana Gernhardt, Işıl AltıntaşYan Liu, Tahamtan Ahmadi, Minh H. Dinh, Daniela Hoehn, Elena Favaro, Brian Elliott, Catherine Thieblemont, Julie M. Vose

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study'. Together they form a unique fingerprint.

Immunology and Microbiology